NCT04832269View on ClinicalTrials.gov

Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Multiple Sclerosis
Interventions
OTHER

Exposure to methylprednisolone during pregnancy

Exposure to methylprednisolone during pregnancy in the context of an MS relapse therapy

Trial Locations (2)

44791

RECRUITING

Ruhr University of Bochum, Bochum

07747

RECRUITING

University Hospital Jena, Jena

All Listed Sponsors
collaborator

Ruhr University of Bochum

OTHER

collaborator

Interdisciplinary Center of Clinical Research of the Medical Faculty Jena

UNKNOWN

collaborator

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

Jena University Hospital

OTHER

NCT04832269 - Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour | Biotech Hunter | Biotech Hunter